Reuters logo
BRIEF-FDA accepts Bristol-Myers Squibb’s application for Opdivo
October 16, 2017 / 8:26 PM / a month ago

BRIEF-FDA accepts Bristol-Myers Squibb’s application for Opdivo

Oct 16 (Reuters) - Bristol-Myers Squibb Co

* U.S. Food and Drug Administration (fda) accepts Bristol-Myers Squibb’s application for Opdivo (nivolumab) in patients with resected high-risk advanced melanoma and grants priority review Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below